Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscleblind proteins regulate alternative splicing.

Thai H Ho1, Nicolas Charlet-B, Michael G Poulos

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

The EMBO Journal
|July 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker study of pembrolizumab in patients with advanced rare cancers.

Cell reports. Medicine·2026
Same author

Opioid-Sparing Multimodal Analgesia versus Standard Analgesia in Hip Fracture Surgery: A Prospective Study.

Journal of orthopaedic case reports·2026
Same author

SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-XL in Clear Cell Renal Cell Carcinoma.

Cancer research·2026
Same author

SHAPE-MaP-Based Assessment of the Structure of Citrus Tristeza Virus Long Non-Coding RNA.

Viruses·2026
Same author

RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report.

Journal of neuromuscular diseases·2026

Muscleblind (MBNL) proteins regulate alternative splicing of key genes, cardiac troponin T (cTNT) and insulin receptor (IR), which are misregulated in myotonic dystrophy (DM). This reveals a crucial role for MBNL proteins in DM RNA pathogenesis.

Area of Science:

  • Molecular Biology
  • Genetics
  • RNA Biology

Background:

  • The muscleblind (MBNL) protein family is linked to myotonic dystrophy (DM) pathogenesis.
  • Disrupted pre-mRNA splicing is a hallmark of DM's RNA-mediated disease model.
  • CELF proteins were previously implicated in DM pathogenesis and splicing regulation.

Purpose of the Study:

  • To elucidate the specific function of MBNL proteins in DM.
  • To investigate the role of MBNL proteins in the alternative splicing of DM-misregulated pre-mRNAs.
  • To understand the interplay between MBNL and CELF proteins in regulating splicing.

Main Methods:

  • Demonstrated MBNL protein regulation of cardiac troponin T (cTNT) and insulin receptor (IR) pre-mRNA alternative splicing.
  • Investigated the antagonistic relationship between MBNL and CELF proteins on cTNT and IR splicing.

Related Experiment Videos

  • Characterized distinct MBNL and CELF binding sites and MBNL's independence from CELF binding sites.

    • Main Results:

    • MBNL proteins oppositely regulate alternative splicing of cTNT and IR exons.
    • CELF proteins antagonize the splicing patterns promoted by MBNL for both cTNT and IR.
    • MBNL regulation of splicing does not depend on the presence of CELF-binding sites.

    Conclusions:

    • MBNL proteins play a direct role in regulating alternative splicing of critical pre-mRNAs implicated in DM.
    • The findings support a model where DM pathogenesis involves loss of MBNL and/or gain of CELF activity, disrupting splicing.
    • This provides a mechanistic link between MBNL protein function and the RNA-mediated pathology of myotonic dystrophy.